Title
Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy
Effect of Omega-3 Supplementation on Body Composition, Functional Capacity, Inflammatory Profile and Quality of Life in Cervix Cancer Patients Undergoing Chemoradiotherapy
Phase
N/ALead Sponsor
Brazilian National Cancer InstituteStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
SarcopeniaIntervention/Treatment
icosapent ethyl olive ...Study Participants
40Cancer cachexia is a complex metabolic process affecting up to 80% of patients suffering from an advanced-stage cancer. Moreover, 20 to 40% of all cancer deaths are caused directly by cachexia. Recently, omega-3 fatty acids have gained interest for their beneficial effects in cancer cachexia. Moreover, nutritional supplementation enriched with omega-3 could potentially maintain body weight in cancer patients undergoing intensive treatment.
The investigators aims in this study is to evaluate the effect of omega-3 supplementation on body composition, functional capacity, inflammatory profile and quality of life in cervix cancer patients undergoing chemoradiotherapy.
patients included in this group will take 2g (4 capsules) per day of eicosapentaenoic acid.
patients included in this group will take 4 capsules per day of olive oil.
Group who will receive 2g eicosapentaenoic (4 capsules) acid per day during the chemoradiotherapy protocol.
Group who will receive olive oil per day (4 capsules) during the chemoradiotherapy protocol.
Inclusion Criteria: Cervix cancer at FIGO stage II and III Chemoradiotherapy treatment proposal (cisplatin + radiotherapy) Nutritional diagnosis of pre-cachexia ou cachexia Exclusion Criteria: metastasis (FIGO stage IV) Nutritional diagnosis of refractary cachexia